Brief: Allarity Granted Hearing Before Nasdaq Panel To Present Plan Of Regaining Compliance
27/06/2024 13:38
June 27 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY GRANTED HEARING BEFORE NASDAQ PANEL TO PRESENT
PLAN OF
REGAINING COMPLIANCE
Source text for Eikon: ID:nGNXbqf0jY
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic